BioSpace News Archive

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced progress with development, regulatory and manufacturing activities associated with a nasal spray for protection against COVID-19 based on the company’s proprietary antiviral dendrimer, SPL7013.

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided additional information concerning the proposals to be considered at its adjourned 2020 annual meeting of stockholders, which will resume on September 3, 2020 at 10:00 a.m. Pacific Time.

University of Michigan spinout readies for clinical trials with lead candidate ASX-100, a novel spherical particle that releases a safe and effective anti-inflammatory agent, salicylic acid, directly to over-reactive immune cells

Sentry Data Systems, Inc., a leader in automated pharmacy procurement, utilization management, and 340B compliance, and its Agilum division have partnered with Actifio, the pioneer of copy data management, to provide near-immediate virtual database access to use existing data for in-depth analytics and what-if COVID-19 testing.

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Clinerion, a worldwide leader in medical data informatics with a global research network comprised of 30.2 million patients online across 69 healthcare organizations in 15 countries. This partnership will accelerate time to market by shortening patient re

Life Science Washington announced today the launch of “Find Your Best Life in Washington,” a campaign to encourage top talent nationwide to learn more about the abundant job opportunities across the more than 1,100 life science companies in Washington state.

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the acquisition of CerSci Therapeutics, a clinical-stage biotechnology company with worldwide rights to a portfolio of novel compounds for neurological conditions, including non-opioid therapies for acute and chronic pain.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for a generic version of Lidocaine Patch, 5%. Lidocaine Patch, 5% is the generic version of Lidoderm Patch, 5% for treatment of post-herpetic neuralgia.

Ernst & Young LLP (EY US) today announced that J. Kelly Ganjei, CEO of Cognate BioServices, Inc. was named an Entrepreneur Of The Year® 2020 Southeast Award finalist

Medexus Pharmaceuticals Inc. announced that it will be presenting at the LD 500 Investor conference being held virtually on September 1-4, 2020.